These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 23683843)

  • 1. Colonoscopic surveillance of first-degree relatives of colorectal cancer patients in a faecal occult blood screening programme.
    Sassoli de Bianchi P; Campari C; Mancini S; Giuliani O; Landi P; Paterlini L; Naldoni C; Finarelli AC; Falcini F; Ponz de Leon M; Sassatelli R; Borciani E; Fornari F; Gatti G; Zatelli M; Zurlini C; Rossi F; Corradini R; Olivetti R; Manfredi M; Baldazzi P; Nannini R; Zanarini S; Matarese VG; Palmonari C; Triossi O; Gordini S; Vattiato R; Colamartini A; Palazzi M; Severi M; Briganti L; Giovanardi M; Casale C; Bucchi L
    Cancer Epidemiol; 2013 Aug; 37(4):469-73. PubMed ID: 23683843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High uptake of colonoscopy in first-degree relatives of patients with colorectal cancer in a healthcare region: a population-based, prospective study.
    Armelao F; Orlandi PG; Tasini E; Franceschini G; Franch R; Paternolli C; de Pretis G
    Endoscopy; 2010 Jan; 42(1):15-21. PubMed ID: 20066589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of colorectal cancer and adenomas in the families of patients with adenomas: a population-based study in Utah.
    Tuohy TM; Rowe KG; Mineau GP; Pimentel R; Burt RW; Samadder NJ
    Cancer; 2014 Jan; 120(1):35-42. PubMed ID: 24150925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interval faecal occult blood testing in a colonoscopy based screening programme detects additional pathology.
    Bampton PA; Sandford JJ; Cole SR; Smith A; Morcom J; Cadd B; Young GP
    Gut; 2005 Jun; 54(6):803-6. PubMed ID: 15888788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased risk of colorectal neoplasia among family members of patients with colorectal cancer: a population-based study in Utah.
    Samadder NJ; Curtin K; Tuohy TM; Rowe KG; Mineau GP; Smith KR; Pimentel R; Wong J; Boucher K; Burt RW
    Gastroenterology; 2014 Oct; 147(4):814-821.e5; quiz e15-6. PubMed ID: 25042087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Colonoscopic screening in first-degree relatives of patients with sporadic colorectal cancer].
    Scintu F; Canalis C; Capra F; D'Alia G; Giordano M; Mocci P; Pisano M; Casula G
    Ann Ital Chir; 2000; 71(6):693-9. PubMed ID: 11347322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.
    Dekker N; van Rossum LG; Van Vugt-van Pinxteren M; van Stiphout SH; Hermens RP; van Zelst-Stams WA; van Oijen MG; Laheij RJ; Jansen JB; Hoogerbrugge N
    Eur J Cancer; 2011 Jul; 47(10):1571-7. PubMed ID: 21367600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Screening for colorectal cancer in high-risk and intermediate-risk subject: what's the best tool?].
    Trevisani L; Cifalà V; Sartori S; Tombesi P; Matarese V; Pezzoli A; Abbasciano V
    Recenti Prog Med; 2009 Feb; 100(2):68-72. PubMed ID: 19350797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study.
    Gimeno-García AZ; Quintero E; Nicolás-Pérez D; Hernández-Guerra M; Parra-Blanco A; Jiménez-Sosa A
    Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1062-7. PubMed ID: 19307978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low risk of colorectal cancer and advanced adenomas more than 10 years after negative colonoscopy.
    Brenner H; Haug U; Arndt V; Stegmaier C; Altenhofen L; Hoffmeister M
    Gastroenterology; 2010 Mar; 138(3):870-6. PubMed ID: 19909750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenoma, advanced adenoma and colorectal cancer prevalence in asymptomatic 40- to 49-year-old subjects with a first-degree family history of colorectal cancer.
    Del Vecchio Blanco G; Cretella M; Paoluzi OA; Caruso A; Mannisi E; Servadei F; Romeo S; Grasso E; Sileri P; Giannelli M; Biancone L; Palmieri G; Pallone F
    Colorectal Dis; 2013 Sep; 15(9):1093-9. PubMed ID: 23627814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan.
    Yang KC; Liao CS; Chiu YH; Yen AM; Chen TH
    J Med Screen; 2006; 13 Suppl 1():S8-13. PubMed ID: 17227635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A direct comparison of the prevalence of advanced adenoma and cancer between surveillance and screening colonoscopies.
    Crispin A; Mansmann U; Munte A; Op den Winkel M; Göke B; Kolligs FT
    Digestion; 2013; 87(3):170-5. PubMed ID: 23635429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk stratification and detection of new colorectal neoplasms after colorectal cancer screening with faecal occult blood test: experiences from a Danish screening cohort.
    Bjerrum A; Milter MC; Andersen O; Fischer A; Lynge E
    Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1433-7. PubMed ID: 26352132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
    van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
    Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
    Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
    Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance colonography for the detection of colorectal neoplasia in asymptomatic adults.
    Graser A; Melzer A; Lindner E; Nagel D; Herrmann K; Stieber P; Schirra J; Mansmann U; Reiser MF; Göke B; Kolligs FT
    Gastroenterology; 2013 Apr; 144(4):743-750.e2. PubMed ID: 23415805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of colorectal cancer with faecal occult blood test screening.
    Paimela H; Malila N; Palva T; Hakulinen T; Vertio H; Järvinen H
    Br J Surg; 2010 Oct; 97(10):1567-71. PubMed ID: 20603855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
    Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
    Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colonoscopy requirements of population screening for colorectal cancer in New Zealand.
    Green T; Richardson A; Parry S
    N Z Med J; 2012 Jun; 125(1356):85-95. PubMed ID: 22729063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.